title: Enhanced cognitive activity--over and above social or physical activity--is required to protect Alzheimer's mice against cognitive impairment, reduce Abeta deposition, and increase synaptic immunoreactivity.
abstract: Although social, physical, and cognitive activities have each been suggested to reduce the risk of Alzheimer's disease (AD), epidemiologic studies cannot determine which activity or combination of activities is most important. To address this question, mutant APP transgenic AD mice were reared long-term in one of four housing conditions (impoverished, social, social+physical, or complete enrichment) from 1(1/2) through 9 months of age. Thus, a stepwise layering of social, physical, and enhanced cognitive activity was created. Behavioral evaluation in a full battery of sensorimotor, anxiety, and cognitive tasks was carried out during the final 5 weeks of housing. Only AD mice raised in complete enrichment (i.e., enhanced cognitive activity) showed: (1) protection against cognitive impairment, (2) decreased brain beta-amyloid deposition, and (3) increased hippocampal synaptic immunoreactivity. The protection provided by enhanced cognitive activity spanned multiple cognitive domains (working memory, reference learning, and recognition/identification). Cognitive and neurohistologic benefits of complete enrichment occurred without any changes in blood cytokine or corticosterone levels, suggesting that enrichment-dependent mechanisms do not involve changes in the inflammatory response or stress levels, respectively. These results indicate that the enhanced cognitive activity of complete enrichment is required for cognitive and neurologic benefit to AD mice-physical and/or social activity are insufficient. Thus, our data suggest that humans who emphasize a high lifelong level of cognitive activity (over and above social and physical activities) will attain the maximal environmental protection against AD.
authors: The Johnnie B. Byrd Alzheimer's Center and Research Institute, Tampa, FL 33613, USA.
authors: Jennifer R
authors: JR
authors: Cracchiolo
authors: Takashi
authors: T
authors: Mori
authors: Stanley J
authors: SJ
authors: Nazian
authors: Jun
authors: J
authors: Tan
authors: Huntington
authors: H
authors: Potter
authors: Gary W
authors: GW
authors: Arendash
mesh_terms: D000544:Alzheimer Disease / Q000150:complications / Q000235:genetics / Q000503:physiopathology*; D016229:Amyloid beta-Peptides / Q000378:metabolism; D000704:Analysis of Variance; D000818:Animals; D001921:Brain / Q000473:pathology / Q000503:physiopathology; D003071:Cognition; D003072:Cognition Disorders / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D003131:Combined Modality Therapy; D003345:Corticosterone / Q000097:blood; D016207:Cytokines / Q000097:blood; D016002:Discriminant Analysis; D004195:Disease Models, Animal; D004777:Environment; D005106:Exploratory Behavior / Q000502:physiology*; D007150:Immunohistochemistry; D018782:Maze Learning / Q000502:physiology*; D051379:Mice; D008818:Mice, Neurologic Mutants; D008822:Mice, Transgenic; D009043:Motor Activity; D011340:Problem Solving / Q000502:physiology*; D011897:Random Allocation; D012931:Social Environment; D013569:Synapses / Q000378:metabolism
chemical_list: D016229:Amyloid beta-Peptides; D016207:Cytokines; D003345:Corticosterone
references: Neurobiol Aging. 2003 Jul-Aug;24(4):615-26
references: 12714119
references: J Neurosci. 2005 Sep 21;25(38):8680-5
references: 16177036
references: Neurobiol Aging. 2004 Oct;25(9):1153-67
references: 15312961
references: Neuroreport. 2004 Aug 6;15(11):1751-4
references: 15257141
references: Neurobiol Aging. 2007 Jun;28(6):831-44
references: 16730391
references: Am J Epidemiol. 2002 Jun 15;155(12):1081-7
references: 12048221
references: Trends Neurosci. 2002 Jun;25(6):295-301
references: 12086747
references: J Neurol Neurosurg Psychiatry. 1999 Feb;66(2):177-83
references: 10071096
references: Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3440-5
references: 11248097
references: Neurology. 2001 Dec 26;57(12):2236-42
references: 11756603
references: Neuroscience. 1997 Sep;80(2):313-20
references: 9284337
references: Nat Neurosci. 1999 Mar;2(3):266-70
references: 10195220
references: Nature. 2000 Dec 21-28;408(6815):975-9
references: 11140684
references: Physiol Behav. 2000 Sep 15;70(5):425-9
references: 11110995
references: Prog Neuropsychopharmacol Biol Psychiatry. 2001 Apr;25(3):609-20
references: 11371000
references: Genes Brain Behav. 2005 Jun;4(4):240-52
references: 15924556
references: DNA Cell Biol. 2001 Nov;20(11):737-44
references: 11788052
references: Acta Neurol Scand. 2002 May;105(5):365-71
references: 11982487
references: Neuroscience. 2004;127(3):601-9
references: 15283960
references: Behav Neurosci. 2003 Jun;117(3):478-84
references: 12802876
references: Neurology. 2002 Dec 24;59(12):1910-4
references: 12499482
references: Appl Neuropsychol. 1997;4(3):160-4
references: 16318479
references: Nat Rev Neurosci. 2000 Dec;1(3):191-8
references: 11257907
references: Physiol Behav. 2004 Oct 15;82(5):765-76
references: 15451640
references: Neuroscience. 2006 Nov 3;142(4):941-52
references: 16938404
references: Psychol Sci. 2003 Mar;14(2):125-30
references: 12661673
references: Eur J Neurosci. 2004 Nov;20(10):2580-90
references: 15548201
references: J Clin Psychol. 1990 Mar;46(2):190-3
references: 2324303
references: Pharmacol Biochem Behav. 2003 Dec;76(3-4):481-6
references: 14643847
references: J Neurosci. 2002 Mar 1;22(5):1858-67
references: 11880515
references: J Am Geriatr Soc. 2003 Apr;51(4):459-65
references: 12657064
references: Neurology. 2004 Aug 10;63(3):498-503
references: 15304581
references: Ann Intern Med. 2006 Jan 17;144(2):73-81
references: 16418406
references: Neuropsychologia. 2004;42(3):335-45
references: 14670572
references: Neurobiol Dis. 2006 Aug;23(2):351-61
references: 16733088
references: Biol Psychiatry. 2006 Dec 15;60(12):1314-23
references: 16806094
references: Behav Brain Res. 2004 Jul 9;152(2):307-14
references: 15196798
references: Alzheimer Dis Assoc Disord. 2001 Jan-Mar;15(1):1-9
references: 11236819
references: Neuroscience. 2003;121(1):1-7
references: 12946694
references: Brain Res. 2004 Jun 25;1012(1-2):29-41
references: 15158158
references: N Engl J Med. 2003 Jun 19;348(25):2508-16
references: 12815136
references: Am J Epidemiol. 2005 Apr 1;161(7):639-51
references: 15781953
references: Am J Pathol. 2006 Aug;169(2):544-52
references: 16877355
references: Acta Psychiatr Scand. 2006 Aug;114(2):75-90
references: 16836595
references: Neuroscience. 2005;130(3):667-84
references: 15590151
references: J Neurosci. 2005 May 25;25(21):5217-24
references: 15917461
references: Cell. 2005 Mar 11;120(5):701-13
references: 15766532
references: J Appl Physiol (1985). 2006 Oct;101(4):1237-42
references: 16778001
references: Nat Neurosci. 2002 Dec;5(12):1288-93
references: 12402041
references: J Neurosci. 2005 Apr 27;25(17):4217-21
references: 15858047
references: J Neuropathol Exp Neurol. 2003 Dec;62(12):1220-7
references: 14692698
references: Physiol Behav. 2001 Jul;73(4):649-58
references: 11495671
references: JAMA. 1994 Apr 6;271(13):1004-10
references: 8139057
references: Neurobiol Dis. 2003 Aug;13(3):273-82
references: 12901842
references: Brain Res. 2001 Feb 9;891(1-2):42-53
references: 11164808
references: Behav Brain Res. 2004 Aug 12;153(1):107-21
references: 15219712
references: Neuroscience. 2004;123(4):813-9
references: 14751275
references: Am J Geriatr Psychiatry. 2004 Jul-Aug;12(4):395-402
references: 15249277
references: JAMA. 2004 Sep 22;292(12):1447-53
references: 15383515
references: Psychol Med. 2006 Apr;36(4):441-54
references: 16207391
references: J Neurosci. 2001 Sep 15;21(18):7340-8
references: 11549744
references: Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8368-72
references: 8078889
references: Neuroscience. 1997 Dec;81(3):689-97
references: 9316021
references: Neurosci Res. 2003 Sep;47(1):55-63
references: 12941447